共 243 条
[1]
Coates AS(2015)Tailoring therapies–improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Ann Oncol Off J Eur Soc Med Oncol 26 1533-1546
[2]
Winer EP(2015)Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients BMJ (Clin Res ed) 351 1796-1804
[3]
Goldhirsch A(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol Off J Am Soc Clin Oncol 30 164-172
[4]
Gelber RD(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet (London, England) 384 1441-1446
[5]
Gnant M(2015)Pathological complete response in neoadjuvant treatment of breast cancer Ann Surg Oncol 22 1275-1281
[6]
Piccart-Gebhart M(2008)Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol Off J Am Soc Clin Oncol 26 646-674
[7]
Thurlimann B(2011)Hallmarks of cancer: the next generation Cell 144 218-230
[8]
Senn HJ(2013)The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer Crit Rev Oncol Hematol 88 1555-1561
[9]
Saadatmand S(2012)Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma Anticancer Res 32 2995-2998
[10]
Bretveld R(2011)Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer Anticancer Res 31 55-59